Ā | Transient wheezing (nā=ā14) | Persistent wheezing (nā=ā54) | Late-onset wheezing (nā=ā17) | Statistics | p |
---|---|---|---|---|---|
Information from recruitment | |||||
Total virus positive [n (%)] | 6 (42.9) | 28 (51.9) | 5 (29.4) | Ļ2=ā2.68 | 0.281 |
RV positive [n (%)]a | 2 (14.3) | 20 (37.0) | 3 (17.6) | Ļ2=ā3.85 | 0.150 |
RSV positive [n (%)]a | 1 (7.1) | 8 (14.8) | 1 (5.9) | Ļ2=ā0.91 | 0.703 |
PIV positive [n (%)]a | 2 (14.3) | 3 (5.6) | 0 (0.0) | Ļ2=ā2.45 | 0.239 |
hMPV positive [n (%)]a | 0 (0.0) | 0 (0.0) | 1 (5.9) | Ļ2=ā3.43 | 0.365 |
Bocavirus positive [n (%)]a | 0 (0.0) | 1 (1.9) | 0 (0.0) | Ļ2=ā1.12 | 1.000 |
Flu positive [n (%)]a | 1 (7.1) | 0 (0.0) | 0 (0.0) | Ļ2=ā3.82 | 0.165 |
Serum IgE test (nā=ā45) | nā=ā7 | nā=ā29 | nā=ā9 | Ā | Ā |
Total IgE (ku/L) | 59.8āĀ±ā35.1 | 193.7āĀ±ā206.4 | 237.7āĀ±ā202.7 | ā | ā |
Log transformed total IgE | 0.7āĀ±ā0.4 | 2.1āĀ±ā0.4 | 2.3āĀ±ā0.3 | Fā=ā5.03 | 0.011 |
Atopy | 4 (57.1) | 24 (82.8) | 9 (100.0) | Fā=ā4.36 | 0.076 |
Aeroallergens positive (Phad) [n (%)]a | 1 (14.3) | 11 (37.9) | 7 (77.8) | Ļ2=ā6.71 | 0.031 |
Mould mix positive (MX1) (nā=ā38)a | 1 (16.7) | 6 (25.0) | 5 (62.5) | Ļ2=ā4.16 | 0.128 |
House dust mite positive (HDM) (nā=ā37)a | 0 (0.0) | 7 (30.4) | 4 (50.0) | Ļ2=ā3.88 | 0.167 |
Food allergens positive [n (%)]a | 2 (28.6) | 15 (51.7) | 5 (55.6) | Ļ2=ā1.39 | 0.623 |
Ā EOS in peripheral blood (nā=ā68) | nā=ā10 | nā=ā44 | nā=ā14 | Ā | Ā |
Ā Percentage (%) | 2.60āĀ±ā2.54 | 3.65āĀ±ā2.41 | 5.06āĀ±ā2.27 | Fā=ā3.24 | 0.045 |
Ā Absolute count (Ćā109/L) | 0.27āĀ±ā0.24 | 0.39āĀ±ā0.30 | 0.49āĀ±ā0.30 | Fā=ā2.56 | 0.085 |
Parental asthma history [n (%)]a | 1 (7.1) | 5 (9.3) | 1 (5.9) | Ļ2ā=ā0.23 | 1.000 |
Information from follow-up | |||||
Rhinitis ever [n (%)] | 2 (14.3) | 34 (63.0) | 15 (88.2) | Ļ2ā=ā18.00 | 0.000 |
Current rhinitis [n (%)] | 2 (14.3) | 27 (50.0) | 10 (58.8) | Ļ2ā=ā7.14 | 0.028 |
Eczema ever [n (%)] | 8 (57.1) | 36 (66.7) | 10 (58.8) | Ļ2ā=ā0.64 | 0.727 |
Current eczema [n (%)]a | 1 (7.1) | 7 (13.0) | 3 (17.6) | Ļ2ā=ā0.74 | 0.804 |